{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:11:52Z","timestamp":1760897512351},"reference-count":52,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T00:00:00Z","timestamp":1089936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Cyclooxygenasen (COX)\u20101 und COX\u20102 sind die Schrittmacherenzyme in der Prostaglandinbiosynthese und repr\u00e4sentieren die molekularen Targets f\u00fcr nicht\u2010steroidale Entz\u00fcndungshemmer. In gesunden Geweben von Erwachsenen wird in der Regel COX\u20101, nicht jedoch COX\u20102 exprimiert. Nach Schnittverletzung der Haut oder Ausl\u00f6sung einer akuten irritativen Kontaktdermatitis wird COX\u20102 transient in der Epidermis gebildet. Insbesondere die Entwicklung von UV\u2010induziertem Erythem und \u00d6dem aber auch von Hauttumoren werden ma\u00dfgeblich durch die Aktivit\u00e4t von COX\u20102 beeinflu\u00dft. Plattenepithelkarzinome und aktinische Keratosen der Haut gelten als ein prominentes Beispiel von epithelialen Tumoren, f\u00fcr die eine permanente \u00dcberexpression der COX\u20102 im Tumorparenchym, im entz\u00fcndlichen Tumorinfiltrat und in Tumorgef\u00e4\u00dfen ein hervorstechendes Merkmal ist. Mehrstufenkarzinogeneseversuchen in der Maushaut und Experimenten mit transgenen M\u00e4usen zufolge besteht ein kausaler Zusammenhang zwischen aberranter COX\u20102\u2010Expression und Aktivit\u00e4t im Epithel und der Tumorpromotion und \u2010progression. Die transgene \u00dcberexpression der COX\u20102 verursacht n\u00e4mlich einen autopromovierten Hautph\u00e4notyp, d.\u2003h. das Enzym sensibilisiert das Gewebe drastisch f\u00fcr die Entwicklung von Plattenepithelkarzinomen. Umgekehrt f\u00fchrt die genetische Ausschaltung der COX\u20102, aber auch der COX\u20101, in der Maushaut zu einer reduzierten Tumorlast. Die St\u00f6rung der terminalen Differenzierung der Epidermis scheint ein Hauptmechanismus zu sein, wie COX\u20102 zur epidermalen Tumorbildung beitr\u00e4gt. Aufgrund dieser Erkenntnisse werden COX\u20102\u2010selektive Inhibitoren als vielversprechende Substanzen zur Pr\u00e4vention und Therapie von Hautkrebs eingestuft.<\/jats:p>","DOI":"10.1046\/j.1439-0353.2004.04042.x","type":"journal-article","created":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T16:42:03Z","timestamp":1089996123000},"page":"668-675","source":"Crossref","is-referenced-by-count":14,"title":["Cyclooxygenasen in der Haut"],"prefix":"10.1111","volume":"2","author":[{"given":"Karin","family":"M\u00fcller\u2010Decker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,16]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.69.1.145"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1193"},{"key":"e_1_2_8_4_2","doi-asserted-by":"crossref","unstructured":"BergerJ MollerDE.The mechanisms of action of PPARs Annu Rev Med2002;53:409\u200a\u2013\u200a435.","DOI":"10.1146\/annurev.med.53.082901.104018"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0595lte"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb1196-897"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-11879"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01454.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","unstructured":"SteeleVE HawkET VinerJL LubetRA. Mechanisms and applications of non\u2010steroidal anti\u2010inflammatory drugs in the chemoprevention of cancer. Mut Res 2003; 523\u200a\u2013\u200a524.","DOI":"10.1016\/S0027-5107(02)00329-9"},{"key":"e_1_2_8_10_2","doi-asserted-by":"crossref","unstructured":"Gasparini G Longo R Sarmiento R Morabito A. Inhibitors of cyclo\u2010oxygenase 2: A new class of anticancer agents? The Lancet Oncol 2003; 4: 605\u200a\u2013\u200a615.","DOI":"10.1016\/S1470-2045(03)01220-8"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.53.082901.103952"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00158-6"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12473.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4068"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<648::AID-IJC6>3.0.CO;2-D"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.121574098"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.6.823"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3090263"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.044545"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19501.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05065.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199608000-00005"},{"key":"e_1_2_8_23_2","first-page":"147","article-title":"Diclofenac and indomethacin influence the healing of normal and ischaemic incisional wounds in skin","volume":"37","author":"Quirinia A","year":"1996","journal-title":"Ann Plast Surg"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475X.2003.11106.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"crossref","unstructured":"Mizuno H Sakamoto C Matsuda K Wada K Uchida T Hogushi H Akamatsu T Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterol 1997; 112: 387\u200a\u2013\u200a397.","DOI":"10.1053\/gast.1997.v112.pm9024292"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.2.367"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12140.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000035024.75914.39"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.992"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1993.21"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb01650.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113416"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(80)90767-6"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199809)23:1<36::AID-MC5>3.0.CO;2-F"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12495.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.4.727"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(95)00166-2"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.5.723"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206537"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12676722"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/120347540200600508"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(00)00089-7"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.10141"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-008X(03)00301-6"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1253"},{"key":"e_1_2_8_46_2","doi-asserted-by":"crossref","unstructured":"Subbaramaiah K Altorki N Chung WJ Mestre JR Sampat A Dannenberg AJ. Inhibition of cyclooxygenase\u20102 gene expression by p53. J Biol Chem 1999; 274: 10911\u200a\u2013\u200a10915.","DOI":"10.1074\/jbc.274.16.10911"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200112000-00005"},{"key":"e_1_2_8_48_2","first-page":"303","article-title":"Expression of cyclooxygenase 2 in human malignant melanoma","volume":"61","author":"Denkert C","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_8_49_2","first-page":"3395","article-title":"Deficiency of either cyclooxygenase (COX)\u20101 or COX\u20102 alters epidermal differentiation and reduces mouse skin tumorigenesis","volume":"62","author":"Tiano HF","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192323799"},{"key":"e_1_2_8_51_2","doi-asserted-by":"crossref","unstructured":"FischerSM ContiCJ VinerJ AldazCM LubetRA. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV\u2010induced skin tumors in mice. Carcinogenesis.2003;24:945\u200a\u2013\u200a952.","DOI":"10.1093\/carcin\/bgg046"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01324.x"},{"key":"e_1_2_8_53_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.02-1192fje","article-title":"Genetic deficiency or pharmacological inhibition of cyclooxygenase\u20101 or \u20102 induces mouse keratinocyte differentiation in vitro and in vivo","volume":"18","author":"Akunda JK","year":"2004","journal-title":"FASEB J"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0353.2004.04042.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0353.2004.04042.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:42:56Z","timestamp":1697215376000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0353.2004.04042.x"}},"subtitle":["Cyclooxygenases in the skin"],"short-title":[],"issued":{"date-parts":[[2004,7,16]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1046\/j.1439-0353.2004.04042.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0353.2004.04042.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,16]]}}}